查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1574662

2024年生物製药管材全球市场报告

Biopharmaceutical Tubing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年生物製药管材市场规模将快速成长。 2028年，这一数字将以11.4%的复合年增长率成长至66.5亿美元。预测期内的预期成长被认为是由于生物製药产量增加、监管政策更加严格、对高效无污染生物製程的需求不断增长、安全措施加强、药品研发投资增加等。在此期间预计的主要趋势包括一次性系统的进步、管道材料的创新、客製化管道解决方案的开发以及管道设计的改进。

个人化医疗的日益普及预计将推动生物製药管市场的扩大。个人化医疗是一种根据每位患者的特征来客製化医疗保健决策、实践、介入和治疗的方法。随着基因研究的进步使得治疗策略能够根据个人的基因特征、生活方式和特定的健康状况量身定制，这种方法正在普及。生物製药管可确保准确、无菌和可靠的输注，在个人化医疗中发挥重要作用。例如，总部位于美国的会员组织个人化医疗联盟报告称，2022 年核准了 12 种新的个人化药物，约占新核准治疗方法的 34%。与前几年相比，这是一个显着的成长，凸显了个人化医疗在推动生物製药管市场成长中的作用。

生物製药管道市场的主要企业正在透过下一代解决方案（例如生物可吸收管道）来改善其产品供应，以提高先进生物製药应用中的性能、无菌性和流体处理能力。生物可吸收管由逐渐分解并被人体吸收的材料製成，使用后无需拆卸。例如，2023年9月，美国先进聚合物解决方案供应商Zeus宣布定向Absorb。这项创新使医疗设备製造商能够探索 BRS 在冠状动脉疾病治疗之外的应用，有可能在各种手术中取代金属支架。这种新型管材改善了壁厚和尺寸均匀性，提高了雷射切割製程的效率，并提供了更用户友好的支架。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球生物製药管市场：驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球生物製药管市场表现：规模与成长，2018-2023
  • 全球生物製药管市场预测：规模与成长，2023-2028，2033F

第六章 市场细分

  • 全球生物製药管材市场：依产品分類的绩效与预测，2018-2023、2023-2028F、2033F
  • 硅胶管
  • 聚氯乙烯（PVC）管
  • 聚烯管
  • 热可塑性橡胶体管
  • 全球生物製药管市场：依製造流程分類的绩效与预测，2018-2023、2023-2028F、2033F
  • 挤压
  • 硫化
  • 其他製造工艺
  • 全球生物製药管市场：依应用分类的表现与预测，2018-2023、2023-2028F、2033F
  • 製药
  • 医疗设备
  • 研究与开发
  • 其他用途

第 7 章 区域/国家分析

  • 全球生物製药管市场：按地区分類的绩效与预测，2018-2023、2023-2028F、2033F
  • 全球生物製药管材市场：按国家分類的绩效和预测，2018-2023、2023-2028F、2033F

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 生物製药管市场：竞争格局
  • 生物製药管材市场：公司简介
    • Compagnie de Saint-Gobain SA
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • GE HealthCare Technologies Inc.
    • Parker Hannifin Corporation

第31章 其他大型创新企业

  • DuPont de Nemours Inc.
  • Freudenberg Group
  • Medline Industries LP
  • Avantor Inc.
  • Alfa Laval AB
  • REHAU Group
  • WL Gore & Associates Inc.
  • Sartorius AG
  • Elkem ASA
  • Trelleborg AB
  • Bio-Rad Laboratories Inc.
  • Tekni-Plex Inc.
  • Pall Corporation
  • Zeus Company Inc.
  • Watson-Marlow Ltd.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章前瞻性与潜力分析

第36章附录

简介目录
Product Code: r19823

Biopharmaceutical tubing refers to specialized tubing used in the production and handling of biopharmaceutical products. It is engineered to meet rigorous standards for sterility, biocompatibility, and precision to ensure the safe and effective handling of sensitive materials throughout both manufacturing and administration processes.

The main products in the biopharmaceutical tubing market include silicone tubing, polyvinyl chloride (PVC) tubing, polyolefin tubing, and thermoplastic elastomer tubing. Silicone biopharmaceutical tubing is known for its flexibility and high purity, made from silicone rubber and specifically designed for use in the biopharmaceutical industry. Manufacturing processes for these tubes include extrusion and vulcanization, with applications spanning pharmaceuticals, medical devices, research and development, and other areas.

The biopharmaceutical tubing market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical tubing market statistics, including the biopharmaceutical tubing industry global market size, regional shares, competitors with biopharmaceutical tubing market share, detailed biopharmaceutical tubing market segments, market trends, and opportunities, and any further data you may need to thrive in the biopharmaceutical tubing industry. These biopharmaceutical tubing market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biopharmaceutical tubing market size has grown rapidly in recent years. It will grow from $3.88 billion in 2023 to $4.32 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth during the historic period can be attributed to an increased demand for minimally invasive procedures, a growing elderly population, a heightened need for ultra-pure and corrosion-resistant systems, and a surge in the demand for diagnostic equipment and drug delivery systems.

The biopharmaceutical tubing market size is expected to see rapid growth in the next few years. It will grow to $6.65 billion in 2028 at a compound annual growth rate (CAGR) of 11.4%. The anticipated growth in the forecast period can be attributed to increasing biopharmaceutical production, stricter regulatory policies, a rising need for efficient and contamination-free bioprocessing, heightened safety measures, and growing investment in pharmaceutical R&D. Key trends expected during this period include advancements in single-use systems, innovations in tubing materials, development of customized tubing solutions, and improvements in tubing design.

The growing use of personalized medicines is expected to drive the expansion of the biopharmaceutical tubing market. Personalized medicine is an approach that customizes healthcare decisions, practices, interventions, and treatments to match the individual characteristics of each patient. This approach is gaining traction due to advancements in genetic research, which allow for treatment strategies tailored to an individual's genetic profile, lifestyle, and specific health conditions. Biopharmaceutical tubing plays a crucial role in personalized medicine by ensuring precise, sterile, and reliable fluid transfer, which is essential for delivering customized treatments and therapies. For instance, in 2022, the Personalized Medicine Coalition, a US-based membership organization, reported the approval of 12 new personalized medicines, representing about 34% of all newly approved therapies. This marks a significant increase compared to previous years, highlighting the role of personalized medicines in driving the growth of the biopharmaceutical tubing market.

Key players in the biopharmaceutical tubing market are advancing their product offerings with next-generation solutions, such as bioabsorbable tubing, to enhance performance, sterility, and fluid handling for advanced biopharmaceutical applications. Bioabsorbable tubing is made from materials that gradually break down and are absorbed by the body, eliminating the need for removal after use. For example, in September 2023, Zeus Company Inc., a US-based provider of advanced polymer solutions, introduced the Absorv XSE-oriented tubing, a next-generation bioabsorbable product designed for bioresorbable vascular scaffolds (BRS). This innovation allows medical device manufacturers to explore BRS applications beyond treating coronary artery disease and potentially replace metallic stents in various procedures. The new tubing offers improved wall thickness and sizing uniformity, enhancing efficiency during laser cutting processes and resulting in more usable scaffolds.

In February 2024, EQT Private Equity, a Sweden-based investment management firm, acquired Zeus Company Inc. for $3.4 billion. This acquisition aims to support Zeus's growth by investing in additional production capacity, research and development, and operational excellence, particularly in medical tubing technology. Zeus Company Inc. is a US-based manufacturer known for precision polymer extrusions and custom tubing.

Major companies operating in the biopharmaceutical tubing market are Compagnie de Saint-Gobain S.A., Thermo Fisher Scientific Inc., Merck KGaA, GE HealthCare Technologies Inc., Parker Hannifin Corporation, DuPont de Nemours Inc., Freudenberg Group, Medline Industries LP, Avantor Inc., Alfa Laval AB, REHAU Group, W. L. Gore & Associates Inc., Sartorius AG, Elkem ASA, Trelleborg AB, Bio-Rad Laboratories Inc., Tekni-Plex Inc., Pall Corporation, Zeus Company Inc., Watson-Marlow Ltd., Raumedic AG, Qosina, Optinova AB, ESI Ultrapure

North America was the largest region in the biopharmaceutical tubing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical tubing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biopharmaceutical tubing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biopharmaceutical tubing market consists of sales of polytetrafluoroethylene (PTFE) tubing, ethylene-vinyl acetate (EVA) tubing, and rubber tubing. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biopharmaceutical Tubing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biopharmaceutical tubing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biopharmaceutical tubing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biopharmaceutical tubing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Silicone Tubing; Polyvinyl Chloride (PVC) Tubing; Polyolefin Tubing; Thermoplastic Elastomer Tubing
  • 2) By Manufacturing Process: Extrusion; Vulcanization; Other Manufacturing Processes
  • 3) By Application: Pharmaceutical; Medical Devices; Research And Development; Other Applications
  • Companies Mentioned: Compagnie de Saint-Gobain S.A.; Thermo Fisher Scientific Inc.; Merck KGaA; GE HealthCare Technologies Inc.; Parker Hannifin Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biopharmaceutical Tubing Market Characteristics

3. Biopharmaceutical Tubing Market Trends And Strategies

4. Biopharmaceutical Tubing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Biopharmaceutical Tubing Market Size and Growth

  • 5.1. Global Biopharmaceutical Tubing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Biopharmaceutical Tubing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Biopharmaceutical Tubing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biopharmaceutical Tubing Market Segmentation

  • 6.1. Global Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Silicone Tubing
  • Polyvinyl Chloride (PVC) Tubing
  • Polyolefin Tubing
  • Thermoplastic Elastomer Tubing
  • 6.2. Global Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Extrusion
  • Vulcanization
  • Other Manufacturing Processes
  • 6.3. Global Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical
  • Medical Devices
  • Research And Development
  • Other Applications

7. Biopharmaceutical Tubing Market Regional And Country Analysis

  • 7.1. Global Biopharmaceutical Tubing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Biopharmaceutical Tubing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biopharmaceutical Tubing Market

  • 8.1. Asia-Pacific Biopharmaceutical Tubing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biopharmaceutical Tubing Market

  • 9.1. China Biopharmaceutical Tubing Market Overview
  • 9.2. China Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biopharmaceutical Tubing Market

  • 10.1. India Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biopharmaceutical Tubing Market

  • 11.1. Japan Biopharmaceutical Tubing Market Overview
  • 11.2. Japan Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biopharmaceutical Tubing Market

  • 12.1. Australia Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biopharmaceutical Tubing Market

  • 13.1. Indonesia Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biopharmaceutical Tubing Market

  • 14.1. South Korea Biopharmaceutical Tubing Market Overview
  • 14.2. South Korea Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biopharmaceutical Tubing Market

  • 15.1. Western Europe Biopharmaceutical Tubing Market Overview
  • 15.2. Western Europe Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biopharmaceutical Tubing Market

  • 16.1. UK Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biopharmaceutical Tubing Market

  • 17.1. Germany Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biopharmaceutical Tubing Market

  • 18.1. France Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biopharmaceutical Tubing Market

  • 19.1. Italy Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biopharmaceutical Tubing Market

  • 20.1. Spain Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biopharmaceutical Tubing Market

  • 21.1. Eastern Europe Biopharmaceutical Tubing Market Overview
  • 21.2. Eastern Europe Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biopharmaceutical Tubing Market

  • 22.1. Russia Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biopharmaceutical Tubing Market

  • 23.1. North America Biopharmaceutical Tubing Market Overview
  • 23.2. North America Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biopharmaceutical Tubing Market

  • 24.1. USA Biopharmaceutical Tubing Market Overview
  • 24.2. USA Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biopharmaceutical Tubing Market

  • 25.1. Canada Biopharmaceutical Tubing Market Overview
  • 25.2. Canada Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biopharmaceutical Tubing Market

  • 26.1. South America Biopharmaceutical Tubing Market Overview
  • 26.2. South America Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biopharmaceutical Tubing Market

  • 27.1. Brazil Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biopharmaceutical Tubing Market

  • 28.1. Middle East Biopharmaceutical Tubing Market Overview
  • 28.2. Middle East Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biopharmaceutical Tubing Market

  • 29.1. Africa Biopharmaceutical Tubing Market Overview
  • 29.2. Africa Biopharmaceutical Tubing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Biopharmaceutical Tubing Market, Segmentation By Manufacturing Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Biopharmaceutical Tubing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biopharmaceutical Tubing Market Competitive Landscape And Company Profiles

  • 30.1. Biopharmaceutical Tubing Market Competitive Landscape
  • 30.2. Biopharmaceutical Tubing Market Company Profiles
    • 30.2.1. Compagnie de Saint-Gobain S.A.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck KGaA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. GE HealthCare Technologies Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Parker Hannifin Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Biopharmaceutical Tubing Market Other Major And Innovative Companies

  • 31.1. DuPont de Nemours Inc.
  • 31.2. Freudenberg Group
  • 31.3. Medline Industries LP
  • 31.4. Avantor Inc.
  • 31.5. Alfa Laval AB
  • 31.6. REHAU Group
  • 31.7. W. L. Gore & Associates Inc.
  • 31.8. Sartorius AG
  • 31.9. Elkem ASA
  • 31.10. Trelleborg AB
  • 31.11. Bio-Rad Laboratories Inc.
  • 31.12. Tekni-Plex Inc.
  • 31.13. Pall Corporation
  • 31.14. Zeus Company Inc.
  • 31.15. Watson-Marlow Ltd.

32. Global Biopharmaceutical Tubing Market Competitive Benchmarking

33. Global Biopharmaceutical Tubing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Biopharmaceutical Tubing Market

35. Biopharmaceutical Tubing Market Future Outlook and Potential Analysis

  • 35.1 Biopharmaceutical Tubing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Biopharmaceutical Tubing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Biopharmaceutical Tubing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer